Position in GUTS
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$902
-$3,434 QoQ
Shares Held
1,971
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GUTS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Sound Income Strategies, LLC holds $979,373 across 66 Biotechnology names. GUTS ranks #55 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
529 | $236,219 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
111 | $85,763 | |
| 3 | DFTX |
Definium Therapeutics, Inc.
|
3,690 | $69,741 | |
| 4 | MRNA |
Moderna, Inc.
|
837 | $42,519 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
137 | $35,389 | |
| 6 | TECH |
BIO-TECHNE Corp
|
657 | $34,334 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
621 | $24,982 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
393 | $24,641 |
All Filings in GUTS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $902 | 1,971 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $4,336 | 1,971 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $1,590 | 1,000 | Shares | Sole | 2025-10-10 | |
| No filing history on record for this holder in this stock. | ||||||